Comerica Bank
FBRX icon

Comerica Bank’s Forte Biosciences FBRX Stock Holding History

Comerica Bank’s Portfolio FBRX Stock Details FBRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		$4.09K Hold
150
– – ﹤0.01% 3439
2025
Q3 		$2.25K Sell
150
-7
-4% -$81 ﹤0.01% 3513
2025
Q2 		$2.03K Buy
157
+2
+1% +$17 ﹤0.01% 3509
2025
Q1 		$1.2K Buy
155
+99
+177% +$1.17K ﹤0.01% 3545
2024
Q4 		$1.27K Buy
+56
New +$666 ﹤0.01% 3546

Other funds holding FBRX

Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $69.6B AUM 42.52% 1-Year Est. Return
FAM
Fred Alger Management New York $22.8B AUM 64.63% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
AAA
Affinity Asset Advisors New York $2.21B AUM 431.26% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
CCC
Cable Car Capital San Francisco, California $289M AUM 26.33% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return
WP
Woodline Partners San Francisco, California $32.4B AUM 58.5% 1-Year Est. Return

Comerica Bank's FBRX Position: Q4 2025 in Review

Comerica Bank held its Forte Biosciences (FBRX) position steady in Q4 2025 at 150 shares worth $4.09K. The position accounts for ﹤0.01% of the portfolio, ranked #3439.

Comerica Bank first reported a position in FBRX in Q4 2024 and has held it in 5 quarters since. 59 funds tracked by Wall St. Rank hold FBRX as of Q4 2025.

  • Comerica Bank held 150 shares of Forte Biosciences worth $4.09K as of Q4 2025.
  • Comerica Bank left its Forte Biosciences share count unchanged in Q4 2025.
  • Forte Biosciences made up ﹤0.01% of Comerica Bank's portfolio in Q4 2025, its #3439 holding.
  • Comerica Bank first reported a position in Forte Biosciences in Q4 2024 and has held it in 5 quarters since.
  • 59 funds tracked by Wall St. Rank held Forte Biosciences as of Q4 2025.

Based on Comerica Bank's 13F filing for Q4 2025, filed 29 Jan 2026.